Can you help Dad/Poppa/Pete/Popeye out?

$12,325 donated
Given by 104 generous donors in around 6 months

Help is required for Dads cancer treatment costing $70,000.00 for eight rounds of Keytruda.

Nelson / Tasman

We are trying to buy some more time with Dad and need your help.

As most of you know Dad has been undergoing treatment for Non Hodgkin's Lymphoma since 2008. Recently Dad's Melanoma has become Stage 4 Advanced Squamous Cell Carcinoma and he has been advised by the specialists that he has approximately 6-8 months to live as the cancer is growing at a rapid rate and surgery is not an option.

We have been advised by Dads oncologist of a drug called Pembrolizumab/Keytruda that should be able halt the cancer. Dad requires four rounds to start with, with an infusion once every three weeks, the problem is that Keytruda is not funded in NZ.

Unfortunately this drug that could stop the cancer rapidly spreading is $11,000.00 per round with a total of $70,000.00 over the course of the eight rounds that Dad needs. Dad has had his life insurance money released to pay for at least some of this treatment but unfortunately due to the drug not being funded here in New Zealand we still need more help.

Any and every little bit would really be appreciated and help.

Use of funds

Dads cancer treatment costing $70,000.00 for eight rounds of Keytruda. Any surplus that may be left over will go to ongoing care and treatment.

Read more

Latest donations

bob
bob on 03 Sep 2019
all the best Pete
$20
Erica
Erica on 15 Aug 2019
Thinking of you all and sending lots of love x
$50
Guest Donor
Guest Donor on 07 Aug 2019
All the best with your treatment! Ken, Liz, Mel & Shaun.
Private
Guest Donor
Guest Donor on 07 Aug 2019
All the best, Thinking of you. John & Jo 🍻
Private
Koos and Antonia
Koos and Antonia on 30 Jul 2019
Hang in there Pete xx
$200

Who's involved?

Pete  Fenemor's avatar
Created by Pete Fenemor, paying to a verified bank account of Pete Fenemor
Page Moderated
The page has been checked by our team to make sure it complies with our terms and conditions.

Gallery

Any concerns?

Report this page
This page was created on 11 Jun 2019 and closed on 11 Dec 2019.